Financhill
Sell
49

RDNT Quote, Financials, Valuation and Earnings

Last price:
$55.48
Seasonality move :
-1.02%
Day range:
$55.39 - $57.20
52-week range:
$45.00 - $93.65
Dividend yield:
0%
P/E ratio:
1,513.25x
P/S ratio:
2.26x
P/B ratio:
4.63x
Volume:
421K
Avg. volume:
598.1K
1-year change:
-7.29%
Market cap:
$4.2B
Revenue:
$1.8B
EPS (TTM):
-$0.43

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
RDNT
RadNet
$488.1M $0.16 6.17% -227.93% $71.57
DGX
Quest Diagnostics
$2.7B $2.57 13.76% 26.89% $184.10
GH
Guardant Health
$211.2M -$0.52 19.22% -38.34% $59.66
ISPC
iSpecimen
$2.9M -- 6.09% -- --
LH
Labcorp Holdings
$3.5B $4.18 7.41% 102.85% $279.06
MEHCQ
23andMe Holding
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
RDNT
RadNet
$55.48 $71.57 $4.2B 1,513.25x $0.00 0% 2.26x
DGX
Quest Diagnostics
$168.09 $184.10 $18.8B 21.25x $0.80 1.84% 1.88x
GH
Guardant Health
$50.25 $59.66 $6.2B -- $0.00 0% 8.00x
ISPC
iSpecimen
$1.05 -- $2.6M -- $0.00 0% 0.17x
LH
Labcorp Holdings
$249.62 $279.06 $20.9B 28.86x $0.72 1.15% 1.60x
MEHCQ
23andMe Holding
$4.92 -- $135.6M -- $0.00 0% 0.67x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
RDNT
RadNet
52.93% 2.389 25.47% 1.88x
DGX
Quest Diagnostics
45.82% 0.438 30.74% 1.10x
GH
Guardant Health
128.98% 3.057 21.19% 3.61x
ISPC
iSpecimen
-- 1.894 -- 0.28x
LH
Labcorp Holdings
40.13% 0.994 28.53% 1.28x
MEHCQ
23andMe Holding
-- 8.800 -- 0.48x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
RDNT
RadNet
$17.9M -$17.6M -1.55% -2.91% -3.37% -$7.4M
DGX
Quest Diagnostics
$863M $346M 7.26% 13.14% 13.12% $197M
GH
Guardant Health
$128.7M -$111M -39.31% -8518.58% -46.24% -$67.1M
ISPC
iSpecimen
$400.2K -$1.6M -239.85% -249.02% -154.88% -$1.1M
LH
Labcorp Holdings
$948M $332.4M 5.27% 9.01% 9.9% -$107.5M
MEHCQ
23andMe Holding
$17.5M -$48M -298.86% -298.86% -106.32% -$42.1M

RadNet vs. Competitors

  • Which has Higher Returns RDNT or DGX?

    Quest Diagnostics has a net margin of -8.05% compared to RadNet's net margin of 8.3%. RadNet's return on equity of -2.91% beat Quest Diagnostics's return on equity of 13.14%.

    Company Gross Margin Earnings Per Share Invested Capital
    RDNT
    RadNet
    3.8% -$0.51 $2.1B
    DGX
    Quest Diagnostics
    32.54% $1.94 $12.9B
  • What do Analysts Say About RDNT or DGX?

    RadNet has a consensus price target of $71.57, signalling upside risk potential of 29%. On the other hand Quest Diagnostics has an analysts' consensus of $184.10 which suggests that it could grow by 9.52%. Given that RadNet has higher upside potential than Quest Diagnostics, analysts believe RadNet is more attractive than Quest Diagnostics.

    Company Buy Ratings Hold Ratings Sell Ratings
    RDNT
    RadNet
    5 0 0
    DGX
    Quest Diagnostics
    8 9 0
  • Is RDNT or DGX More Risky?

    RadNet has a beta of 1.409, which suggesting that the stock is 40.86% more volatile than S&P 500. In comparison Quest Diagnostics has a beta of 0.492, suggesting its less volatile than the S&P 500 by 50.805%.

  • Which is a Better Dividend Stock RDNT or DGX?

    RadNet has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quest Diagnostics offers a yield of 1.84% to investors and pays a quarterly dividend of $0.80 per share. RadNet pays -- of its earnings as a dividend. Quest Diagnostics pays out 38% of its earnings as a dividend. Quest Diagnostics's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios RDNT or DGX?

    RadNet quarterly revenues are $471.4M, which are smaller than Quest Diagnostics quarterly revenues of $2.7B. RadNet's net income of -$37.9M is lower than Quest Diagnostics's net income of $220M. Notably, RadNet's price-to-earnings ratio is 1,513.25x while Quest Diagnostics's PE ratio is 21.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for RadNet is 2.26x versus 1.88x for Quest Diagnostics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    RDNT
    RadNet
    2.26x 1,513.25x $471.4M -$37.9M
    DGX
    Quest Diagnostics
    1.88x 21.25x $2.7B $220M
  • Which has Higher Returns RDNT or GH?

    Guardant Health has a net margin of -8.05% compared to RadNet's net margin of -46.77%. RadNet's return on equity of -2.91% beat Guardant Health's return on equity of -8518.58%.

    Company Gross Margin Earnings Per Share Invested Capital
    RDNT
    RadNet
    3.8% -$0.51 $2.1B
    GH
    Guardant Health
    63.28% -$0.77 $865.6M
  • What do Analysts Say About RDNT or GH?

    RadNet has a consensus price target of $71.57, signalling upside risk potential of 29%. On the other hand Guardant Health has an analysts' consensus of $59.66 which suggests that it could grow by 18.73%. Given that RadNet has higher upside potential than Guardant Health, analysts believe RadNet is more attractive than Guardant Health.

    Company Buy Ratings Hold Ratings Sell Ratings
    RDNT
    RadNet
    5 0 0
    GH
    Guardant Health
    15 3 0
  • Is RDNT or GH More Risky?

    RadNet has a beta of 1.409, which suggesting that the stock is 40.86% more volatile than S&P 500. In comparison Guardant Health has a beta of 1.442, suggesting its more volatile than the S&P 500 by 44.2%.

  • Which is a Better Dividend Stock RDNT or GH?

    RadNet has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Guardant Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. RadNet pays -- of its earnings as a dividend. Guardant Health pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios RDNT or GH?

    RadNet quarterly revenues are $471.4M, which are larger than Guardant Health quarterly revenues of $203.5M. RadNet's net income of -$37.9M is higher than Guardant Health's net income of -$95.2M. Notably, RadNet's price-to-earnings ratio is 1,513.25x while Guardant Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for RadNet is 2.26x versus 8.00x for Guardant Health. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    RDNT
    RadNet
    2.26x 1,513.25x $471.4M -$37.9M
    GH
    Guardant Health
    8.00x -- $203.5M -$95.2M
  • Which has Higher Returns RDNT or ISPC?

    iSpecimen has a net margin of -8.05% compared to RadNet's net margin of -156.82%. RadNet's return on equity of -2.91% beat iSpecimen's return on equity of -249.02%.

    Company Gross Margin Earnings Per Share Invested Capital
    RDNT
    RadNet
    3.8% -$0.51 $2.1B
    ISPC
    iSpecimen
    37.85% -$0.71 $1.7M
  • What do Analysts Say About RDNT or ISPC?

    RadNet has a consensus price target of $71.57, signalling upside risk potential of 29%. On the other hand iSpecimen has an analysts' consensus of -- which suggests that it could grow by 5614.29%. Given that iSpecimen has higher upside potential than RadNet, analysts believe iSpecimen is more attractive than RadNet.

    Company Buy Ratings Hold Ratings Sell Ratings
    RDNT
    RadNet
    5 0 0
    ISPC
    iSpecimen
    0 0 0
  • Is RDNT or ISPC More Risky?

    RadNet has a beta of 1.409, which suggesting that the stock is 40.86% more volatile than S&P 500. In comparison iSpecimen has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock RDNT or ISPC?

    RadNet has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. iSpecimen offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. RadNet pays -- of its earnings as a dividend. iSpecimen pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios RDNT or ISPC?

    RadNet quarterly revenues are $471.4M, which are larger than iSpecimen quarterly revenues of $1.1M. RadNet's net income of -$37.9M is lower than iSpecimen's net income of -$1.7M. Notably, RadNet's price-to-earnings ratio is 1,513.25x while iSpecimen's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for RadNet is 2.26x versus 0.17x for iSpecimen. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    RDNT
    RadNet
    2.26x 1,513.25x $471.4M -$37.9M
    ISPC
    iSpecimen
    0.17x -- $1.1M -$1.7M
  • Which has Higher Returns RDNT or LH?

    Labcorp Holdings has a net margin of -8.05% compared to RadNet's net margin of 6.36%. RadNet's return on equity of -2.91% beat Labcorp Holdings's return on equity of 9.01%.

    Company Gross Margin Earnings Per Share Invested Capital
    RDNT
    RadNet
    3.8% -$0.51 $2.1B
    LH
    Labcorp Holdings
    28.34% $2.52 $13.9B
  • What do Analysts Say About RDNT or LH?

    RadNet has a consensus price target of $71.57, signalling upside risk potential of 29%. On the other hand Labcorp Holdings has an analysts' consensus of $279.06 which suggests that it could grow by 11.8%. Given that RadNet has higher upside potential than Labcorp Holdings, analysts believe RadNet is more attractive than Labcorp Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    RDNT
    RadNet
    5 0 0
    LH
    Labcorp Holdings
    12 5 0
  • Is RDNT or LH More Risky?

    RadNet has a beta of 1.409, which suggesting that the stock is 40.86% more volatile than S&P 500. In comparison Labcorp Holdings has a beta of 0.819, suggesting its less volatile than the S&P 500 by 18.086%.

  • Which is a Better Dividend Stock RDNT or LH?

    RadNet has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Labcorp Holdings offers a yield of 1.15% to investors and pays a quarterly dividend of $0.72 per share. RadNet pays -- of its earnings as a dividend. Labcorp Holdings pays out 32.59% of its earnings as a dividend. Labcorp Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios RDNT or LH?

    RadNet quarterly revenues are $471.4M, which are smaller than Labcorp Holdings quarterly revenues of $3.3B. RadNet's net income of -$37.9M is lower than Labcorp Holdings's net income of $212.8M. Notably, RadNet's price-to-earnings ratio is 1,513.25x while Labcorp Holdings's PE ratio is 28.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for RadNet is 2.26x versus 1.60x for Labcorp Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    RDNT
    RadNet
    2.26x 1,513.25x $471.4M -$37.9M
    LH
    Labcorp Holdings
    1.60x 28.86x $3.3B $212.8M
  • Which has Higher Returns RDNT or MEHCQ?

    23andMe Holding has a net margin of -8.05% compared to RadNet's net margin of -220.04%. RadNet's return on equity of -2.91% beat 23andMe Holding's return on equity of -298.86%.

    Company Gross Margin Earnings Per Share Invested Capital
    RDNT
    RadNet
    3.8% -$0.51 $2.1B
    MEHCQ
    23andMe Holding
    38.79% -$3.78 -$26.7M
  • What do Analysts Say About RDNT or MEHCQ?

    RadNet has a consensus price target of $71.57, signalling upside risk potential of 29%. On the other hand 23andMe Holding has an analysts' consensus of -- which suggests that it could fall by -57.76%. Given that RadNet has higher upside potential than 23andMe Holding, analysts believe RadNet is more attractive than 23andMe Holding.

    Company Buy Ratings Hold Ratings Sell Ratings
    RDNT
    RadNet
    5 0 0
    MEHCQ
    23andMe Holding
    0 0 0
  • Is RDNT or MEHCQ More Risky?

    RadNet has a beta of 1.409, which suggesting that the stock is 40.86% more volatile than S&P 500. In comparison 23andMe Holding has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock RDNT or MEHCQ?

    RadNet has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. 23andMe Holding offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. RadNet pays -- of its earnings as a dividend. 23andMe Holding pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios RDNT or MEHCQ?

    RadNet quarterly revenues are $471.4M, which are larger than 23andMe Holding quarterly revenues of $45.1M. RadNet's net income of -$37.9M is higher than 23andMe Holding's net income of -$99.3M. Notably, RadNet's price-to-earnings ratio is 1,513.25x while 23andMe Holding's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for RadNet is 2.26x versus 0.67x for 23andMe Holding. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    RDNT
    RadNet
    2.26x 1,513.25x $471.4M -$37.9M
    MEHCQ
    23andMe Holding
    0.67x -- $45.1M -$99.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

What Is the Ceiling for IONQ Stock?
What Is the Ceiling for IONQ Stock?

IonQ (NYSE:IONQ) is a quantum computing startup that, like many…

Can FUBO Stock Double?
Can FUBO Stock Double?

TV streaming service Fubo (NYSE:FUBO) has seen incredible returns so…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 12

MiNK Therapeutics [INKT] is up 727.94% over the past day.

Buy
51
NEGG alert for Jul 12

Newegg Commerce [NEGG] is up 74.03% over the past day.

Buy
68
ATRO alert for Jul 12

Astronics [ATRO] is up 16.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock